IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i2p189-d196750.html
   My bibliography  Save this article

Controversies Surrounding Vitamin D: Focus on Supplementation and Cancer

Author

Listed:
  • Salvatore Minisola

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Federica Ferrone

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Vittoria Danese

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Veronica Cecchetti

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Jessica Pepe

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Cristiana Cipriani

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

  • Luciano Colangelo

    (Department of Internal Medicine and Medical Disciplines, “Sapienza” Rome University, 00161 Rome, Italy)

Abstract

There has recently been a huge number of publications concerning various aspects of vitamin D, from the physiological to therapeutic fields. However, as a consequence of this very fast-growing scientific area, some issues still remain surrounded by uncertainties, without a final agreement having been reached. Examples include the definitions of vitamin D sufficiency and insufficiency, (i.e., 20 vs. 30 ng/mL), the relationship between 25-hydroxyvitamin D (25(OH)D) and parathyroid hormone, (i.e., linear vs. no linear), the referent to consider, (i.e., total vs. free determination), the utility of screening versus universal supplementation, and so on. In this review, the issues related to vitamin D supplementation in subjects with documented hypovitaminosis, and the role of vitamin D in cancer will be concisely considered. Daily, weekly, or monthly administration of cholecalciferol generally leads to essentially similar results in terms of an increase in 25(OH)D serum levels. However, we should also consider possible differences related to a number of variables, (i.e., efficiency of intestinal absorption, binding to vitamin D binding protein, and so on). Thus, adherence to therapy may be more important than the dose regimen chosen in order to allow long-term compliance in a sometimes very old population already swamped by many drugs. It is difficult to draw firm conclusions at present regarding the relationship between cancer and vitamin D. In vitro and preclinical studies seem to have been more convincing than clinical investigations. Positive results in human studies have been mainly derived from post-hoc analyses, secondary end-points or meta-analyses, with the last showing not a decrease in cancer incidence but rather in mortality. We must therefore proceed with a word of caution. Until it has been clearly demonstrated that there is a causal relationship, these positive “non-primary, end-point results” should be considered as a background for generating new hypotheses for future investigations.

Suggested Citation

  • Salvatore Minisola & Federica Ferrone & Vittoria Danese & Veronica Cecchetti & Jessica Pepe & Cristiana Cipriani & Luciano Colangelo, 2019. "Controversies Surrounding Vitamin D: Focus on Supplementation and Cancer," IJERPH, MDPI, vol. 16(2), pages 1-10, January.
  • Handle: RePEc:gam:jijerp:v:16:y:2019:i:2:p:189-:d:196750
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/2/189/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/16/2/189/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. David Scott & Peter R. Ebeling, 2019. "Vitamin D and Public Health," IJERPH, MDPI, vol. 16(5), pages 1-3, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:2:p:189-:d:196750. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.